Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial in metastatic melanoma evaluates lymphodepletion followed by adoptive cell transfer, with or without dendritic cell…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the combination of BGB-A445 with tislelizumab in patients with select advanced solid tumors, includ…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating fecal microbiota transplantation for immune-checkpoint inhibitor–induced diarrhea or colitis in patients w…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma [EARLY_Phase 1]
An early Phase 1 trial evaluating the combination of imiquimod and pembrolizumab in patients with stage IIIB-IV melanoma has completed with …
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The NOTION study investigates in-home sampling of cytokines in cancer patients receiving immunotherapy, and the trial has completed. The con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases [Phase 2]
Phase 2 trial evaluating stereotactic brain-directed radiation with or without Aguix gadolinium-based nanoparticles for brain metastases; th…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]
Roche is conducting a dose-escalation Phase 1/2 trial of a PD-1/LAG-3 bispecific antibody in patients with advanced or metastatic solid tumo…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors [Phase 1]
Phase 1 study of PF-08046031 in advanced melanoma and other solid tumors was terminated. The trial status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating a gene-modified immune cell therapy after a conditioning regimen for metastatic melanoma and other metas…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A clinical trial is evaluating benefits and harms of cannabis/cannabinoid use among cancer patients treated in community oncology clinics; r…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in combination with pembrolizumab for metastatic solid tumors has completed, enrolling patients with me…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: AI-based Medical Device Validation for Early Melanoma Detection
Completed validation study of an AI-based medical device for early melanoma detection; results have been posted.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma [Phase 1]
A Phase 1-1b clinical trial is evaluating the safety, preliminary efficacy, and dosimetry of study drug A9-3408 in patients with metastatic …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) [Phase 1, Phase 2]
A pediatric Phase 1/2 study of pembrolizumab (Keytruda) in children with advanced solid tumors or lymphoma is currently recruiting. The tria…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma [Phase 1]
Phase 1 pharmacokinetic similarity study comparing AVT32-DRL_PB with Keytruda in participants with fully resected melanoma; not yet recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response [NA]
A terminated clinical trial (NCT02439008) investigating early biomarkers of tumor response to high-dose hypofractionated radiotherapy across…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] [Phase 3]
This Phase 3 trial IGNYTE-3 compares a VO oncolytic therapy plus nivolumab against physician's choice in advanced melanoma that progressed a…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
This clinical trial investigates how biological, genetic, and constitutional factors, plus non-invasive monitoring, can help assess individu…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of AMXT 1501 and DFMO with standard therapies in patients with advanced solid tumors, …
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma [Phase 1]
Phase 1 trial evaluating the safety and tolerability of an intravenously administered cancer vaccine in patients with advanced melanoma has …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
A Mayo Clinic-sponsored phase 1/2 trial evaluating a personalized neoantigen peptide-based vaccine in combination with pembrolizumab for adv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial update from Novartis assessing LXH254 combinations for efficacy and safety in patients with previously treated unre…
-
CLINICAL_TRIALS other · 2026-03-12Clinical Trial Update: Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating a personalized neo-antigen peptide vaccine for advanced cancers (metastatic breast cancer, melanoma, and n…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial [NA]
The ICEMAN trial is evaluating narrow excision versus wide excision for adults with invasive cutaneous melanoma at clinical stages IA–IB to …